Indonesia vs Mexico: HIV/AIDS deaths averted by antiretroviral therapy
Indonesia
14,389 deaths
in 2024
Mexico
12,379 deaths
in 2024
Indonesia rank
17th
Mexico rank
19th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Indonesia
- Mexico
How they compare
Indonesia currently reports 14,389 deaths against 12,379 deaths in Mexico, a difference of 2,010 deaths.
That makes Indonesia's figure about 1.2 times Mexico's.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Mexico ahead.
Indonesia ranks 17th and Mexico ranks 19th of 157 countries.
Across the 4 decades both report, Indonesia averaged higher in 1 and Mexico in 3.
Head to head by decade
| Decade | Indonesia | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 1990s | -0.0142 deaths | 379.05 deaths | 379.06 deaths | Mexico |
| 2000s | 655.3 deaths | 3,660 deaths | 3,005 deaths | Mexico |
| 2010s | 6,279 deaths | 8,109 deaths | 1,830 deaths | Mexico |
| 2020s | 12,043 deaths | 11,646 deaths | 396.68 deaths | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Indonesia or Mexico?
- Indonesia, at 14,389 deaths against 12,379 deaths in Mexico as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Indonesia and Mexico?
- 2,010 deaths, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Mexico?
- 35 years are reported by both, from 1990 to 2024.
- How do Indonesia and Mexico rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Indonesia ranks 17th and Mexico ranks 19th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.